Incheon, South Korea

Hyun Bin Kang

This inventor holds 1 USPTO granted patent. Top assignees: Ahn-Gook Pharmaceutical Co., Ltd., Rstech Corporation. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyun Bin Kang. Retrieved from https://idiyas.com/inventor/hyun-bin-kang-jheeoagb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hyun Bin Kang: Innovator in Pharmaceutical Chemistry

Introduction

Hyun Bin Kang is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of chiral compounds. His innovative work has led to advancements in the preparation of highly optical pure carvedilol, a medication used for treating heart conditions.

Latest Patents

Hyun Bin Kang holds a patent for a process titled "Process for the preparation of highly optical pure carvedilol." This invention relates to an efficient method for synthesizing chiral carvedilol using a chiral oxazolidin-2-one or oxazolidin-2-thione as a key intermediate. The process involves a series of reactions that activate a hydroxyl group and ultimately produce the targeted chiral carvedilol under mild conditions. This method is notable for its simplicity and efficiency, as it does not require extraordinary purification procedures and maintains optical purity.

Career Highlights

Throughout his career, Hyun Bin Kang has worked with reputable companies in the pharmaceutical industry. He has been associated with Ahn-Gook Pharmaceutical Co., Ltd. and Rstech Corporation, where he has contributed to various research and development projects. His expertise in pharmaceutical chemistry has been instrumental in advancing the field.

Collaborations

Hyun Bin Kang has collaborated with several professionals in his field, including Chang Woo Jong and Seong-Jin Kim. These collaborations have fostered innovation and have led to the successful development of new pharmaceutical processes.

Conclusion

Hyun Bin Kang is a distinguished inventor whose work in the preparation of chiral carvedilol has made a significant impact in pharmaceutical chemistry. His innovative processes and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…